DefiniGEN
Latest round
- Series A
Last raised
- Nov 2020
Total raised
- $12M
Investors
- 10
About DefiniGEN
Established in 2012 and based in the UK, DefiniGEN Limited operates as a biotechnology company that develops in providing disease model human cells, including hepatocytes, pancreatic beta cells, and intestinal organoids.
Who invested in DefiniGEN
10 investors across 4 rounds
See all investors in DefiniGEN
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about DefiniGEN
Who invested in DefiniGEN?
DefiniGEN has 10 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has DefiniGEN raised?
DefiniGEN has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did DefiniGEN last raise money?
DefiniGEN's most recent round on record is a Series A, in Nov 2020.
What does DefiniGEN do?
Established in 2012 and based in the UK, DefiniGEN Limited operates as a biotechnology company that develops in providing disease model human cells, including hepatocytes, pancreatic beta cells, and intestinal organoids.
Where is DefiniGEN headquartered?
DefiniGEN is headquartered in Cambridge, UK.
Which VCs invest in companies like DefiniGEN?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at DefiniGEN's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like DefiniGEN? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.